EMA in push for more paediatric drug trials
July 24, 2015Medical Communications, Research and Development EMA, European Medicines Agency, clinical trials, drug development, paediatrics
The European Medicines Agency has relaxed some of its rules around the development of drugs in children, in order to …
European Commission approves Merck’s Keytruda for melanoma drug
July 23, 2015Sales and Marketing
The European Commission has approved Merck’s Keytruda (pembrolizumab) as a skin cancer treatment. Keytruda, the company’s successful anti-PD-L1 therapy and …
Cancer and immunology drugs drive strong Roche sales performance
July 23, 2015Sales and Marketing Roche, Severin Schwan, financials
Sales at Roche rose 6% in the first half of 2015, buoyed by “significant growth of sales and immunology medicines”, …
Lilly, Biogen and Roche debut Alzheimer’s disease drug results
July 22, 2015Research and Development Alzheimer's, Alzheimer's disease, Biogen, Conference, Eli Lilly, Roche, lilly
Big pharma companies have posted mixed results in trials of several potential new treatments for Alzheimer’s disease. But the results, …
BMS halts Opdivo kidney cancer trial early
July 22, 2015Research and Development BMS, Bristol-Myers Squibb, European Commission, Kidney cancer, opdivo, renal cell carcinoma
Bristol-Myers Squibb has stopped its Phase III study of its immunotherapy drug Opdivo in people with kidney cancer early after …
Cancer Drugs Fund assessment to be handed over to NICE
July 22, 2015Medical Communications, Research and Development CDF, Cancer, Cancer Drugs Fund, NHS, NHS England, NHSE, NICE, cost effectiveness, cost-effectiveness
NICE will oversee the evaluation of Cancer Drugs Fund treatments in future, under new plans due for consultation by NHS …
New ABPI executive director appointed
July 21, 2015Manufacturing and Production, Research and Development, Sales and Marketing ABPI, Richard Corbett
The UK pharma trade body the ABPI has appointed Richard Corbett as its new executive director of commercial. Corbett will …
Parliamentary launch for UK life sciences group
July 21, 2015Manufacturing and Production, Research and Development All Party Parliamentary Group on Life Sciences, Kit Malthouse, george freeman, government, lobbying, parliament
A Parliamentary body has been created to highlight the contribution the life sciences sector makes to the economy, and boost …
Amgen’s Repatha wins PCSK9 heart drug race
July 21, 2015Sales and Marketing Amgen, European Commission, PCKS9, Repatha, evolocumab, high cholesterol
The European Commission has signed off on Amgen’s Repatha, making it the first in a new class of cholesterol-lowering drugs …
Sandoz and pharma division boost Novartis sales
July 21, 2015Sales and Marketing Alcon, Novartis, Sandoz, financial performance, financial results, income, profits, sales
Sales at Novartis reached $12.7 billion in the second quarter of 2015, while its operating income was $2.3 billion, the …
Novartis and Pfizer to close factories in India
July 21, 2015Manufacturing and Production India, Novartis, Pfizer, Sandoz, manufacturing
Two big pharma firms have announced they will close manufacturing facilities in India as they seek to restructures their global …
FDA bans drug imports from Indian plant
July 21, 2015Manufacturing and Production Emcure, FDA, GMP, Good Manufacturing Practices, India, compliance, manufacturing, production, safety
The FDA has blocked US imports from the manufacturing plants of a major Indian pharmaceutical firm over safety fears. The …
Valeant in $800 million deal for Amoun Pharma
July 20, 2015Sales and Marketing Amoun, Egypt, MENA, Valeant, acquisitions
Valeant is striking out in the acquisitions market yet again, having agreed an $800 million deal to buy Egypt’s largest …
European Imbruvica approval for Janssen
July 20, 2015Medical Communications, Sales and Marketing B-cell lymphoma, EC, European Commission, Janssen, Waldenström’s Macroglobulinemia, imbruvica, rare cancer
Janssen has received final European sign-off for its oncology treatment Imbruvica (ibrutinib) as a treatment option for adult patients with …
Ruling in transparency case ‘due within days’
July 17, 2015Research and Development EMIG, EU Clinical Trial Regulation, Ethical Medicines Industry Group, Richmond Pharmacology, alltrials, clinical trials, health research authority, hra, sense about science, transparency
A judge is set to rule on a controversial legal challenge to the requirement for the pharma industry to register …
Chugai falls foul of ABPI code for close consultant relationship
July 17, 2015Medical Communications, Sales and Marketing ABPI Code, Chugai, PMCPA, Prescription Medicines Code of Practice Authority
Bosses at Chugai have been rapped by the industry’s code of practice regulator, after a senior manager failed to declare …
Novartis receives WHO nod for malaria drug Coartem
July 17, 2015Manufacturing and Production Coartem, Novartis, WHO, antimalarial, malaria, world health organization
The World Health Organization will add Novartis’ antimalarial treatment Coartem to the prequalified list of vaccines that is supplies to …
AstraZeneca receives US approval for Iressa
July 16, 2015Medical Communications, Sales and Marketing AstraZeneca, FDA, Iressa, lung cancer, non-small cell lung cancer
AstraZeneca’s lung cancer therapy Iressa has been approved by the FDA – four years after the company pulled it from the …
It’s time the industry spoke out about legal challenge to clinical trial transparency
July 16, 2015Research and Development Richmond Pharmacology, alltrials, clinical trials, health research authority, hra, judicial review, legal challenge, sense about science, transparency
The judicial review brought by Richmond Pharmacology against the Health Research Authority – erroneous, a waste of public money and …
Industry awaits outcome of transparency legal challenge
July 16, 2015Research and Development Richmond Pharmacology, alltrials, clinical trials, health research authority, hra, judicial review, legal challenge, sense about science, transparency
A judge will today hear arguments from the Health Research Authority and campaigners who are contesting a judicial review of …
Latest content
Migraine annual economic and quality-of-life burden in UK
bit.bio expands human heart cell portfolio through myriamed partnership
Phoenix Labs acquires Kent Pharma
Astoriom acquires Sampled’s UK stability storage operations
